Trials / Completed
CompletedNCT02594046
The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Pusan National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.
Detailed description
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | stem cell component extract | The Allogeneic Human adipose derived stem cell component extract |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-02-28
- Completion
- 2016-05-28
- First posted
- 2015-11-02
- Last updated
- 2017-04-05
Source: ClinicalTrials.gov record NCT02594046. Inclusion in this directory is not an endorsement.